Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1975 3
1976 1
1977 3
1978 1
1979 2
1980 5
1981 8
1982 9
1983 9
1984 11
1985 17
1986 13
1987 19
1988 23
1989 24
1990 20
1991 21
1992 31
1993 35
1994 27
1995 31
1996 39
1997 41
1998 61
1999 61
2000 65
2001 57
2002 81
2003 73
2004 102
2005 120
2006 154
2007 160
2008 202
2009 229
2010 270
2011 301
2012 344
2013 371
2014 449
2015 520
2016 503
2017 519
2018 673
2019 701
2020 834
2021 908
2022 1006
2023 994
2024 1063
2025 842

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,902 results

Results by year

Filters applied: . Clear all
Page 1
Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation.
Wu W, Sui W, Chen S, Guo Z, Jing X, Wang X, Wang Q, Yu X, Xiong W, Ji J, Yang L, Zhang Y, Jiang W, Yu G, Liu S, Tao W, Zhao C, Zhang Y, Chen Y, Zhang C, Cao Y. Wu W, et al. Among authors: yu g. Cell Metab. 2025 May 6;37(5):1075-1088.e7. doi: 10.1016/j.cmet.2025.01.006. Epub 2025 Feb 19. Cell Metab. 2025. PMID: 39978336 Free article.
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: yu g. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
Homoleptic Organolanthanum-Catalyzed Carbohalogenation.
Yang H, Rajeshkumar T, Liu S, Cong H, Yu G, Wang L, Chen ZY, Wei B, Maron L, Chen YH. Yang H, et al. Among authors: yu g. J Am Chem Soc. 2024 Sep 11;146(36):25361-25370. doi: 10.1021/jacs.4c10445. Epub 2024 Aug 27. J Am Chem Soc. 2024. PMID: 39189853
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Shen L, Zhang Y, Li Z, Zhang X, Gao X, Liu B, Wang Y, Ba Y, Li N, Zhang R, Zhang J, Chen Y, Chen J, Huang M, Fu Y, Liu M, Liu Z, Zhao J, Li W, Wei J, Li C, Xu N, Guo Z, Cao B, Liu L, Nie P, Wan L, Sheng L, Liu Z, He Y, Gu K, Wu G, Wang W, Zhang F, Qiu W, Guo J, Ying J, Pan H, Xu H, Yuan Y, Bai Y, Wang Z, Xu J, Zhao X, Liu H, Zhang X, Dai W, Xu H, Liu M, Xie L, Tang Y, Jin J, Qu X, Fang X, Huang M, Chen H, Zheng Z, Wang Y, Wang D, Li X, Yu G, Liu H, Zhou Y, Zhong D, Zeng S, Kang M, Wang M, Gao Y, Li W, Wang Z, Zhang M, Zhang J, Li Q, Sun S, Zang A, Lin L, Xie M, Zhuang Z, Zhang T, Yao Z, Lu D, Liu W, Hu M, Wang ZM, Li B, Xia M, Zhang J, Ying X, Pardoll DM, Ji J. Shen L, et al. Among authors: yu g. Nat Med. 2025 Apr;31(4):1163-1170. doi: 10.1038/s41591-024-03450-4. Epub 2025 Jan 22. Nat Med. 2025. PMID: 39843940 Clinical Trial.
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials.
Zhao S, Cheng Y, Wang Q, Li X, Liao J, Rodon J, Meng X, Luo Y, Chen Z, Wang W, Yi T, Li Y, Yin Y, Xu H, Yu G, Mi Y, Fan Y, Wainberg ZA, Wang X, Su C, Yu Q, Lai S, Sun L, Zhuang W, Wang X, Yang J, Li Y, Ge J, Li J, Zhang L, Fang W. Zhao S, et al. Among authors: yu g. Nat Med. 2025 Jun;31(6):1976-1986. doi: 10.1038/s41591-025-03638-2. Epub 2025 Apr 10. Nat Med. 2025. PMID: 40210967 Clinical Trial.
Norepinephrine changes behavioral state through astroglial purinergic signaling.
Chen AB, Duque M, Rymbek A, Dhanasekar M, Wang VM, Mi X, Tocquer L, Narayan S, Legorreta EM, Eddison M, Yu G, Wyart C, Prober DA, Engert F, Ahrens MB. Chen AB, et al. Among authors: yu g. Science. 2025 May 15;388(6748):769-775. doi: 10.1126/science.adq5233. Epub 2025 May 15. Science. 2025. PMID: 40373133 Free PMC article.
10,902 results
You have reached the last available page of results. Please see the User Guide for more information.